Related Experiment Video
Updated: Jan 29, 2026
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
Recombinant influenza A viruses as vaccine vectors
Thomas Gerlach1, Husni Elbahesh1, Giulietta Saletti1
1a Research Center for Emerging Infections and Zoonoses (RIZ) , University of Veterinary Medicine Hannover (TiHo) , Hannover , Germany.
Introduction:
Various viruses, including poxviruses, adenoviruses and vesicular stomatitis virus, have been considered as vaccine vectors for the delivery of antigens of interest in the development of vaccines against newly emerging pathogens.
Areas Covered:
Here, we review results that have been obtained with influenza A viruses (IAV) as vaccine vectors. With the advent of reverse genetics technology, IAV-based recombinant vaccine candidates have been constructed that induce protective immunity to a variety of different pathogens of interest, including West Nile virus, Plasmodium falciparum and respiratory syncytial virus. The various cloning strategies to produce effective and attenuated, safe to use IAV-based viral vectors are discussed.
Expert Commentary:
It was concluded that IAV-based vector system has several advantages and holds promise for further development.
More Related Videos
Related Concept Videos
01:09Recombinant DNA
01:51Vaccinations
00:57Viral Recombination
00:50What are Viruses?
02:31Homologous Recombination
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...